Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4208861 | Journal of Cystic Fibrosis | 2010 | 6 Pages |
Abstract
Adverse reactions to antibiotics in patients with cystic fibrosis (CF) are a growing concern. We report the case of a pediatric patient with CF with multiple comorbidities and a history of drug reactions, who developed life-threatening piperacillin-induced immune hemolytic anemia. We review drug-induced hemolytic anemia (DIIHA) in particular, and antibiotic hypersensitivity in CF in general, including the frequency, pathogenesis, and risk factors. Finally, we discuss the treatment options and propose an algorithm for the management of drug-induced hypersensitivity reactions in patients with CF.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Alma Chavez, Amir Mian, Amy M. Scurlock, Douglas Blackall, Gulnur Com,